HCAT Health Catalyst, Inc.
Healthcare$1.25+0.00%OpenMarket Cap: $92.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.68
P/S
0.32
EV/EBITDA
-0.58
DCF Value
$16.55
FCF Yield
9.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
46.0%
Operating Margin
-19.2%
Net Margin
-87.7%
ROE
-99.8%
ROA
-64.4%
ROIC
-18.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $70.8M | 33.4% | $-6.7M | $-111.0M | $— | — |
| Q4 null | $74.7M | 52.7% | $3.3M | $-91.0M | $— | — |
| FY null | $311.1M | 33.5% | $-36.1M | $-178.0M | $— | — |
| Q3 null | $76.3M | 49.5% | $-17.5M | $-22.2M | $— | — |
| Q2 null | $80.7M | 47.4% | $-37.1M | $-41.0M | $— | — |
| Q1 null | $79.4M | 45.6% | $-20.2M | $-23.7M | $— | — |
| Q4 null | $79.6M | 43.6% | $-17.5M | $-20.7M | $— | — |
| FY null | $306.6M | 45.9% | $-69.8M | $-69.5M | $— | — |
| Q3 null | $76.4M | 44.6% | $-13.7M | $-14.7M | $— | — |
| Q2 null | $75.9M | 47.2% | $-15.8M | $-13.5M | $— | — |
| Q1 null | $74.7M | 48.5% | $-22.8M | $-20.6M | $— | — |
| Q4 2023 | $75.1M | 40.6% | $-32.8M | $-30.3M | $-0.53 | — |